Trends in early onset colorectal cancer–related mortality among adults in the United States from 1999-2020. Multi-site blinded validation of a deep learning approach for clinical-grade MSI/dMMR ...

Colorectal adenocarcinoma incidence is decreasing overall but increasing among individuals aged 15 to 34 years, with an APC of 1.75. Pancreatic adenocarcinoma incidence is rising across all age groups ...

From 2000 to 2021, the incidence of pancreatic adenocarcinoma rose among all age groups in the United States, with the highest increase in those aged 15-34 years. During the same period, the overall ...

The most common type of colon cancer is adenocarcinoma, which usually has a favorable outcome if diagnosed and treated early. Screening is an important tool for a prompt diagnosis. Colorectal cancer ...

Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy ...

Please provide your email address to receive an email when new articles are posted on . Rates of pancreatic adenocarcinoma increased significantly among younger individuals than older ones. Colorectal ...

Colorectal cancer is a high disease burden cancer and is the second leading cause of cancer deaths worldwide. The first-line treatment option is surgical resection of cancerous tissue. However, the ...

Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01. Chemoradiotherapy (CRT) followed by sequential tislelizumab (TIS) + CAPOX and TIS ...

Researchers are finally getting to the bottom of a troubling trend. Once considered a disease of older adults, colorectal ...